Tim Walbert, Horizon Therapeutics CEO (via YouTube)
Horizon Therapeutics in takeover talks with Amgen, J&J, Sanofi as potential buyers
Amgen, J&J’s Janssen and Sanofi are all in talks to acquire Horizon Therapeutics, the rare disease biotech disclosed late Tuesday.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
